Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Supporters often stress the possibility for substantial therapeutic gains, principally in diseases where conventional medications have proven ineffective. However, it's to evaluate the considerable financial burden associated with CPI stem cell therapy